← Back
Data updated: Mar 10, 2026
GD SEARLE LLC
Immunology
GD SEARLE LLC is a major pharmaceutical company focused on Immunology.
1940
Since
28
Drugs
-
Trials
34
Approved (2yr)
Key Drugs
No active drugs
Recent Activity
POTASSIUM CHLORIDE 2025-12-22
POTASSIUM CHLORIDE 2025-11-20
POTASSIUM CHLORIDE 2025-10-27
Labeling
LIDOCAINE HYDROCHLORIDE 2025-10-02
Manufacturing (CMC)
LIDOCAINE HYDROCHLORIDE 2025-09-26
Labeling
POTASSIUM CHLORIDE 2025-09-10
LIDOCAINE HYDROCHLORIDE 2025-08-27
Manufacturing (CMC)
LIDOCAINE HYDROCHLORIDE 2025-08-22
Labeling
LIDOCAINE HYDROCHLORIDE 2025-08-22
Labeling
CLORAZEPATE DIPOTASSIUM 2025-08-21
Labeling
SEC Filings
Pro
Loading...
Therapeutic Focus
Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5
Immunology 100%
1 drugs
Pipeline Strength Pro
Loading...
Active (3)
Discontinued (25)
POTASSIUM CHLORIDE LIDOCAINE HYDROCHLORIDE CLORAZEPATE DIPOTASSIUM METARAMINOL BITARTRATE CALAN BEXTRA PROCAINE HYDROCHLORIDE DEMULEN 1/50-21 DEMULEN 1/35-21 DEMULEN 1/35-28 DEMULEN 1/50-28 AMINOPHYLLIN DIULO PRO-BANTHINE ENOVID ENOVID-E ENOVID-E 21 OVULEN-28 OVULEN-21 OVULEN NORINYL 1+80 21-DAY NORINYL 1+80 28-DAY AMMONIUM CHLORIDE CU-7 TATUM-T
Company Info
- First Approval
- 1940-04-19
- Latest
- 2022-04-29
- Applications
- 30
FDA Sponsor Names
GD SEARLE LLCGD SEARLE